NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE267583 Query DataSets for GSE267583
Status Public on May 15, 2024
Title Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Breast cancer patients with estrogen receptor positive tumors face a constant risk of disease recurrence for the remainder of their lives. Dormant tumor cells residing in tissues such as the bone marrow may generate clinically significant metastases many years after initial diagnosis. Previous studies suggest that dormant cells display “stem like” properties (CSCs), which may be regulated by the immune system. Although many studies have examined tumor cell intrinsic characteristics of dormancy, the role of the immune system in controlling dormancy and its escape is not well understood. This scientific gap is due, in part, to a lack of immunocompetent mouse models of breast cancer dormancy with many studies involving human xenografts in immunodeficient mice. To overcome this limitation, we studied dormancy in immunocompetent, syngeneic mouse breast cancer models. We find that PyMT, Met-1 and D2.0R cell lines contain CSCs that display both short- and long-term metastatic dormancy in vivo, which is dependent on the host immune system. Natural killer cells were key for the metastatic dormancy phenotype observed for D2.0R and the role of NK cells in regulating CSCs was further investigated. Quiescent D2.0R CSC are resistant to NK cytotoxicity, while proliferative D2.0R CSC were sensitive to NK cytotoxicity both in vitro and in vivo. This resistance was mediated, in part, by the expression of Bach1 and Sox2 transcription factors. NK killing was enhanced by the STING agonist MSA-2. Collectively, our findings demonstrate the important role of immune regulation of breast tumor dormancy and highlight the importance of utilizing immunocompetent models to study this phenomenon.
 
Overall design D2.0R tumor cells were labeled with celltrace far red and cultured for one week in 2% FBS DMEM media. After a week of culture CTFR+ label retaining cells (quiescent) and CTFR- non-label retaining cells (proliferative) were FACS sorted.
 
Contributor(s) Bushnell GG, Wicha M
Citation(s) 37873211
Submission date May 15, 2024
Last update date May 15, 2024
Contact name Grace Bushnell
E-mail(s) ggb@umich.edu
Organization name University of Michigan
Department Internal Medicine
Lab Wicha Lab
Street address 2800 Plymouth Rd NCRC B26
City Ann Arbor
State/province MI
ZIP/Postal code 48109
Country USA
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (9)
GSM8269380 7053-GB-1
GSM8269381 7053-GB-2
GSM8269382 7053-GB-3
Relations
BioProject PRJNA1111891

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE267583_gene_expected_count.annot.txt.gz 1.4 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap